These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12163124)

  • 1. Comparison of incadronate and alfacalcidol on increased bone turnover caused by ovariectomy in rats.
    Teramura K; Fukushima S; Nozaki K; Kokubo S; Takahashi K
    Eur J Pharmacol; 2002 Aug; 449(1-2):191-6. PubMed ID: 12163124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incadronate inhibits osteoporosis in ovariectomized rats.
    Teramura K; Fukushima S; Iwai T; Nozaki K; Kokubo S; Takahashi K
    Eur J Pharmacol; 2002 Dec; 457(1):51-6. PubMed ID: 12460643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium supplementation does not reproduce the pharmacological efficacy of alfacalcidol for the treatment of osteoporosis in rats.
    Shiraishi A; Ito M; Hayakawa N; Kubota N; Kubodera N; Ogata E
    Calcif Tissue Int; 2006 Mar; 78(3):152-61. PubMed ID: 16525749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis.
    Uchiyama Y; Higuchi Y; Takeda S; Masaki T; Shira-Ishi A; Sato K; Kubodera N; Ikeda K; Ogata E
    Bone; 2002 Apr; 30(4):582-8. PubMed ID: 11934649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of withdrawal of bisphosphonate incadronate disodium (YM175) on bone mineral density, mass, structure, and turnover in the lumbar vertebrae of ovariectomized rats.
    Tamura Y; Miyakoshi N; Itoi E; Abe T; Kudo T; Tsuchida T; Kasukawa Y; Sato K
    J Bone Miner Res; 2001 Mar; 16(3):541-9. PubMed ID: 11277272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.
    Bauss F; Lalla S; Endele R; Hothorn LA
    J Rheumatol; 2002 Oct; 29(10):2200-8. PubMed ID: 12375334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of osteopenia induced by gastrectomy or ovariectomy in young female rats.
    Andersson N; Surve VV; Lehto-Axtelius D; Andersson K; Ryberg B; Ohlsson C; Håkanson R
    Acta Orthop Scand; 2004 Apr; 75(2):201-9. PubMed ID: 15180236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of alfacalcidol on osteoporosis in ovariectomized rats].
    Xia W; Meng X; Xing X
    Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):702-5. PubMed ID: 11798840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
    Weber K; Goldberg M; Stangassinger M; Erben RG
    J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator.
    Arshad M; Sengupta S; Sharma S; Ghosh R; Sawlani V; Singh MM
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):67-78. PubMed ID: 15261309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study.
    Yang X; Chan YH; Muthukumaran P; Dasde S; Teoh SH; Lee T
    Bone; 2011 May; 48(5):1154-63. PubMed ID: 21334474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The advantage of alfacalcidol over vitamin D in the treatment of osteoporosis.
    Shiraishi A; Higashi S; Ohkawa H; Kubodera N; Hirasawa T; Ezawa I; Ikeda K; Ogata E
    Calcif Tissue Int; 1999 Oct; 65(4):311-6. PubMed ID: 10485984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
    Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
    Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats.
    Takeda S; Sakai S; Tanaka K; Tomizawa H; Serizawa K; Yogo K; Urayama K; Hashimoto J; Endo K; Matsumoto Y
    Calcif Tissue Int; 2017 Jul; 101(1):65-74. PubMed ID: 28246925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.